Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
Lídia Blanco-Silvente, Xavier Castells, Marc Sáez, et al.·2017·The International Journal of Neuropsychopharmacology